ADHD Medication Linked to Reduced Mortality Risk, Swedish Study Finds

A comprehensive study in Sweden demonstrates that treating ADHD with medication can significantly lower the risk of early death, particularly from unnatural causes.

• A large Swedish study reveals a 19% reduction in mortality risk for ADHD patients treated with medication over a two-year period.
• The study, published in JAMA, analyzed both natural and unnatural causes of death, finding significant differences in the latter.
• Medication is suggested to alleviate ADHD symptoms that contribute to poor outcomes, such as impulsivity and decision-making.
• The research highlights the importance of early diagnosis and treatment for ADHD to potentially extend life expectancy.
• Despite its strengths, the study acknowledges limitations due to its observational nature and calls for further research.

3 Articles

PsyPost Study Finds Forbes